Cardiac thrombolysis is a medical intervention aimed at dissolving blood clots within the coronary arteries, which are vital vessels supplying the heart muscle with oxygen and nutrients. This procedure is commonly employed in the management of acute myocardial infarction, also known as a heart attack. During a heart attack, a blood clot can obstruct blood flow to a part of the heart, leading to tissue damage and potentially life-threatening complications. Cardiac thrombolysis involves the administration of thrombolytic agents, or clot-busting drugs, to break down the clot and restore blood flow to the affected area of the heart. This timely intervention is crucial in minimizing myocardial damage and improving the chances of a positive outcome. While cardiac thrombolysis has proven effective in certain cases, it is not suitable for all patients, and individual factors such as the time elapsed since the onset of symptoms and the patient's overall health must be carefully considered by healthcare professionals before deciding on this treatment approach.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India